As a result of the COVID-19 pandemic, marijuana sales are skyrocketing as many people are turning to the product to deal with isolation, anxiety, and depression.
Indeed, new market research compiled by Marijuana Business Factbook estimates medical and recreational cannabis sales are on track to grow by 40% this year over 2019, bringing total annual revenue to $15 billion by the end of 2020.
Furthermore, the U.S. marijuana sector alone is estimated to be worth $37 billion by 2024 as more states join the legalization bandwagon. Hence, it has become vital for investors who buy weed stocks to choose those with solid business performance, as such companies have the most potential for share appreciation. Today, let's take a look at two companies that fit the criteria for July.